Services

Online Inquiry

For research use only. Not intended for any clinical use.

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Non-Human Primate (NHP) Large Molecule Quantitation (ELISA, MSD) Service

Are you currently facing complex challenges in pre-clinical drug development, such as the need for precise and reliable large molecule quantitation in NHP studies? Creative Biolabs' NHP Large Molecule Quantitation (ELISA, MSD) service helps you overcome these hurdles and accelerate your research timeline. Our service provides accurate and highly specific data for biotherapeutic development by leveraging advanced immunoassay platforms and extensive NHP resources.

Introduction to Our NHP Large Molecule Quantitation Service

Non-human primates (NHPs) are a critical species in pre-clinical research for large molecule therapeutics, such as monoclonal antibodies, due to their close biological and genetic similarities to humans. These similarities make NHP models ideal for assessing the safety and efficacy of novel biopharmaceuticals before they enter human clinical trials. Accurate quantitation of these large molecules in NHP biological samples is essential for understanding PK and PD profiles, which directly inform dose selection and study design for subsequent human trials.

What Our Service Is

Creative Biolabs' NHP Large Molecule Quantitation service provides a precise and reliable method for measuring the concentration of large molecules in NHP biological matrices. We specialize in two gold-standard immunoassay technologies: ELISA and Meso Scale Discovery (MSD) electrochemiluminescence.

PK Studies: We support PK studies by quantifying therapeutic drug concentrations at various time points after administration, providing crucial data for determining drug exposure and clearance.
TK Studies: Our assays assist in TK studies by correlating drug exposure with potential toxic effects, a key requirement for regulatory submissions.
Immunogenicity Testing: We detect and quantify the presence of anti-drug antibodies (ADA), which can impact a therapeutic's efficacy and safety.

Why Choose Us?

Choosing Creative Biolabs means gaining a partner that understands the nuances of large molecule bioanalysis in NHPs. We transform your challenges into actionable insights by addressing key pain points:

Pain Point: The high cost and limited availability of NHP biological samples.
- Benefit: Our sensitive MSD assays require minimal sample volumes, maximizing the data obtained from each precious sample.
Pain Point: The need for rapid turnaround to maintain project timelines.
- Benefit: Our streamlined workflows and optimized protocols ensure fast, reliable results without compromising quality.
Pain Point: The complexity of developing and validating assays for novel biologics.
- Benefit: Our team of experts customizes and validates assays to fit your specific needs, ensuring they are robust and reproducible for your unique molecule.

Key Benefits of Our Service

Our service is defined by several key advantages that set us apart. We provide a comprehensive solution that combines scientific expertise with state-of-the-art technology.

Exceptional Response Speed: We offer a rapid turnaround time on all projects, allowing you to quickly move from one development stage to the next. Our efficient processes and dedicated project management ensure you receive data on time, every time.
Extensive NHP Resources: Leveraging a broad network of NHP facilities, we have consistent access to a wide range of sample matrices, including serum, plasma, and other biological fluids, from diverse NHP species.
Customization and Flexibility: We recognize that every project is unique. We provide fully customizable assay development and validation, ensuring our methods are perfectly tailored to your therapeutic molecule, matrix, and specific project requirements.
In-Depth Reporting: Our comprehensive data packages include detailed reports on all aspects of the assay, from method validation to sample analysis. We provide raw data, standard curves, and clear interpretations, giving you full transparency and confidence in your results.
High Sensitivity and Wide Dynamic Range: Our use of the MSD platform provides superior sensitivity and a broader dynamic range compared to traditional methods, allowing for accurate quantitation of both high- and low-concentration analytes in the same sample.

How Creative Biolabs' Services Can Assist Your Project?

Our service is designed to provide clear, actionable data that directly addresses the core challenges of large molecule bioanalysis in NHPs. We deliver reliable quantitation for your therapeutic candidates, giving you the confidence to make critical development decisions.

Required Starting Materials

Project Scoping and Material Receipt

Assay Development and Optimization

Method Validation

Sample Analysis

Data Analysis and Reporting

Key Deliverables

Comprehensive lab report detailing the developed and validated method.
Raw data files from the ELISA or MSD plate reader.
Analysis report with quantified large molecule concentrations.
Standard curve data and validation parameters.

Capabilities & Partnerships

Service-Specific Data

Annual Sample Size: Over 50,000 samples analyzed per year.
Turnaround Time (TAT): Typical turnaround of 2 weeks for bioanalytical results.
Study Pass Rate: 99%+ success rate in meeting study endpoints.

Our Valued Partners

Frequently Asked Questions

Q: Why do you offer both ELISA and MSD platforms? What's the difference?

A: Both are powerful immunoassay platforms. ELISA is a traditional, well-established method, while MSD, with its electrochemiluminescence technology, offers superior sensitivity and a wider dynamic range, often requiring less sample volume. We offer both to provide the best fit for your specific project needs and budget. We'd be happy to discuss the best option for your research.

Q: Can you develop a new assay for my specific therapeutic molecule?

A: Absolutely. Our core strength is developing and validating custom assays for novel large molecules. Our team will work with you to design a protocol that is specific, sensitive, and robust for your therapeutic candidate.

Q: How do you handle the limited availability of NHP samples?

A: We understand the value of these precious samples. Our MSD platform is a great solution as it requires minimal sample volume, allowing us to get more data from less material. We also have optimized workflows to minimize waste and ensure every sample is utilized effectively.

Q: How can I be sure your results are accurate and reliable?

A: We perform rigorous method validation according to industry standards. Our validation reports include data on accuracy, precision, linearity, and more, giving you complete confidence in the quality of the results.

Q: What information do I need to provide to start a project?

A: To get started, you'll need to provide information about your large molecule, such as its name, its target, and any available purified material. A brief description of your study objectives and a summary of your materials would also be very helpful.

Contact Us

Creative Biolabs is committed to accelerating your drug discovery and development efforts with our expert NHP Large Molecule Quantitation services. Our team is ready to provide the high-quality data you need to make informed decisions. For more information and to discuss your specific project needs, please contact us.